SEC Form 4 · accession 0001192482-19-000018
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan David Lake
Officer — Chief Financial Officer
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 5:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2019 | F | 979 | $7.41 | D | 13,021 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.